StreetInsider.com News Articles

Form 8-K Nordicus Partners Corp For: Jul 13

Mon, 13 Jul 2026 09:12:00 -0400

si-local-file:///var/storage/secattach/20260713/26760751.html

Form 8-K Nordicus Partners Corp For: Jul 13

Mon, 13 Jul 2026 09:12:00 -0400

si-local-file:///var/storage/secattach/20260713/26760751.html

Form 8-K Nordicus Partners Corp For: Jul 13

Mon, 13 Jul 2026 09:12:00 -0400

si-local-file:///var/storage/secattach/20260713/26760751.html

Form NT 10-K Nordicus Partners Corp For: Mar 31

Mon, 29 Jun 2026 10:03:00 -0400

si-local-file:///var/storage/secattach/20260629/26703401.html

Form NT 10-K Nordicus Partners Corp For: Mar 31

Mon, 29 Jun 2026 10:03:00 -0400

si-local-file:///var/storage/secattach/20260629/26703401.html

Form NT 10-K Nordicus Partners Corp For: Mar 31

Mon, 29 Jun 2026 10:03:00 -0400

si-local-file:///var/storage/secattach/20260629/26703401.html

Form 8-K Nordicus Partners Corp For: Jun 23

Tue, 23 Jun 2026 15:41:00 -0400

si-local-file:///var/storage/secattach/20260623/26679242.html

Form 8-K Nordicus Partners Corp For: Jun 23

Tue, 23 Jun 2026 15:41:00 -0400

si-local-file:///var/storage/secattach/20260623/26679242.html

Form 8-K Nordicus Partners Corp For: Jun 23

Tue, 23 Jun 2026 15:41:00 -0400

si-local-file:///var/storage/secattach/20260623/26679242.html

Orocidin develops novel cGMP manufacturing process in collaboration with Syngene

Mon, 20 Oct 2025 09:00:00 -0400

The partnership addressed complex peptide synthesis and purification challenges to achieve high yield and purity suitable for clinical use

BEVERLY HILLS, California, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Orocidin A/S (“Orocidin”), a subsidiary of Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in supporting Nordic and U.S. life sciences companies in establishing themselves in the U.S. market, announced the development of a unique, cGMP-compliant manufacturing process. The program was executed in partnership with Syngene International Limited (“Syngene”), a leading integrated research, development, and manufacturing services organization.

QR-01

Orocidin develops novel cGMP manufacturing process in collaboration with Syngene

Mon, 20 Oct 2025 09:00:00 -0400

The partnership addressed complex peptide synthesis and purification challenges to achieve high yield and purity suitable for clinical use

QR-01

Orocidin develops novel cGMP manufacturing process in collaboration with Syngene

Mon, 20 Oct 2025 09:00:00 -0400

The partnership addressed complex peptide synthesis and purification challenges to achieve high yield and purity suitable for clinical use

QR-01

Orocidin develops novel cGMP manufacturing process in collaboration with Syngene

Mon, 20 Oct 2025 09:00:00 -0400

The partnership addressed complex peptide synthesis and purification challenges to achieve high yield and purity suitable for clinical use

QR-01

Nordicus Partners names three new board directors

Thu, 07 Aug 2025 09:50:12 -0400

Nordicus Partners Corporation (OTCQB: NORD) announced the appointment of three new board members following the resignation of Henrik Keller and an expansion of the board from three to five members.